Business Description
Description
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.39 | |||||
Equity-to-Asset | 0.44 | |||||
Debt-to-Equity | 0.66 | |||||
Debt-to-EBITDA | 2.41 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 1.44 | |||||
Beneish M-Score | -3.7 | |||||
WACC vs ROIC |
Growth Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 34.2 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
6-1 Month Momentum % | 111.16 | |||||
12-1 Month Momentum % | 88.24 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.57 | |||||
Quick Ratio | 0.94 | |||||
Cash Ratio | 0.58 | |||||
Days Inventory | 316.7 | |||||
Days Sales Outstanding | 53.73 | |||||
Days Payable | 324.68 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -91.1 | |||||
Shareholder Yield % | -3.12 |
Profitability Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 47.86 | |||||
Operating Margin % | -18.5 | |||||
Net Margin % | -0.32 | |||||
FCF Margin % | 43.78 | |||||
ROE % | -0.24 | |||||
ROA % | -0.1 | |||||
ROIC % | -4.71 | |||||
3-Year ROIIC % | 4.34 | |||||
ROC (Joel Greenblatt) % | 204.32 | |||||
ROCE % | 4.08 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Forward PE Ratio | 26.11 | |||||
Price-to-Owner-Earnings | 7.12 | |||||
PS Ratio | 3.98 | |||||
PB Ratio | 2.9 | |||||
Price-to-Free-Cash-Flow | 10.04 | |||||
Price-to-Operating-Cash-Flow | 9.88 | |||||
EV-to-EBIT | 40.96 | |||||
EV-to-EBITDA | 12.14 | |||||
EV-to-Forward-EBITDA | 13.61 | |||||
EV-to-Revenue | 4.4 | |||||
EV-to-Forward-Revenue | 3.47 | |||||
EV-to-FCF | 10.05 | |||||
Price-to-Projected-FCF | 3.63 | |||||
Earnings Yield (Greenblatt) % | 2.44 | |||||
FCF Yield % | 10.94 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:AMYT
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Amryt Pharma PLC Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 243.621 | ||
EPS (TTM) ($) | -0.3 | ||
Beta | 0 | ||
Volatility % | 102.71 | ||
14-Day RSI | 0 | ||
14-Day ATR ($) | 0.029847 | ||
20-Day SMA ($) | 0 | ||
12-1 Month Momentum % | 88.24 | ||
52-Week Range ($) | 6.41 - 14.77 | ||
Shares Outstanding (Mil) | 64.13 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Amryt Pharma PLC Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Amryt Pharma PLC Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Amryt Pharma PLC Frequently Asked Questions
What is Amryt Pharma PLC(AMYT)'s stock price today?
When is next earnings date of Amryt Pharma PLC(AMYT)?
Does Amryt Pharma PLC(AMYT) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |